NSE: VIJAYA · 2 November 2026
- Vijaya Diagnostic Centre Ltd. shares finished the trading day up 0.81% at ₹1,457.40, recovering modestly from an intra-day low of ₹1,429.10 after opening stronger at ₹1,474.50 and reaching a high of ₹1,475.70.
- The board approved the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The total cash consideration is set at approximately ₹46.20 crores, structured at around 8-9x of FY26 IND AS EBITDA. The target business reported a revenue of ₹26.95 crores for FY 2025-26 and provides Vijaya with an established operating base to enter the North-East India diagnostics market.
- Trading volume was 0.51 times the 20-day average daily volume.
Why is Vijaya Diagnostic Centre share price rising on 2 November 2026?
Vijaya Diagnostic Centre Ltd. shares finished the trading day up 0.81% at ₹1,457.40, recovering modestly from an intra-day low of ₹1,429.10 after opening stronger at ₹1,474.50 and reaching a high of ₹1,475.70.
The broader market demonstrated a strong upward push as the Nifty index gained 1.68%. However, the sector performance was muted, with the Nifty Pharma sector benchmark slipping 0.07%, reflecting a divergence where Vijaya Diagnostic managed a mild positive gain despite flat sector conditions. Over short-term and medium-term horizons, the stock has exhibited stable momentum, posting a 5-day return of 4.41% and a 20-day return of 2.06%.
Company fundamentals and recent developments provide ongoing operational context for investors, though no single same-day announcement was issued to explicitly trigger today's minor price increase. The company recently completed procedural requirements for its 24th Annual General Meeting held on September 24, 2026, where shareholders adopted financial statements and approved a final dividend of ₹2 per share. Additionally, the company announced a strategic agreement in September 2026 to acquire Arya Wellness Centre in Guwahati, Assam, for approximately ₹46.20 crores on a slump sale basis, expanding its footprint into North-East India.
61,745 shares traded by 2 November 2026 · 03:30 PM IST. This compares with a 20-day average daily volume of 1.21 lakh shares (0.51 times). The five-day average daily volume was 79,707 shares. Separately, the NSE report for 2 November 2026 showed 29,847 shares delivered, representing 48.34% of that day’s traded volume. The same report recorded 11,951 trades.
The modest 0.81% gain occurred on below-average volume without any direct same-day corporate catalyst. The price action appears consistent with a continuation of recent positive momentum following last week's return performance.
Latest Company Developments
The board approved the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The total cash consideration is set at approximately ₹46.20 crores, structured at around 8-9x of FY26 IND AS EBITDA. The target business reported a revenue of ₹26.95 crores for FY 2025-26 and provides Vijaya with an established operating base to enter the North-East India diagnostics market.
Marks the company's geographical expansion into Assam, establishing a strategic gateway for growth across the North-Eastern region.
General Updates – Investor Presentation – 100% Acquisition of integrated diagnostic business undertaking of Arya Wellness Centre, Guwahati, Asssam.
Appointment of Mr Venkata Naresh Yallapragada as Other of the company effective. September 02, 2026.
Ownership & Transaction Activity
Mutual Fund Holdings
Mutual funds held 31.44% on 30 September 2026. This compares with 30.66% on 30 June 2026, a change of +0.78 percentage points.
The filing reported 27 MF/UTI holders.
What to Watch Next
- Upcoming financial results and operational updates for the quarter ending September 30, 2026.
- Progress on the customary conditions precedent and closing timeline for the acquisition of Arya Wellness Centre in Guwahati.
- Delivery volume trends and institutional participation relative to the 20-day average volume baseline.
- Execution of the calibrated regional expansion strategy across West Bengal and North-East India.
Other Dated Coverage
More Vijaya Diagnostic Centre news and dated analysis →
Frequently Asked Questions
What is the latest Vijaya Diagnostic Centre company news?
The board approved the execution of a Business Transfer Agreement to acquire 100% of the integrated diagnostic business undertaking of Arya Wellness Centre in Guwahati, Assam, on a slump sale basis. The total cash consideration is set at approximately ₹46.20 crores, structured at around 8-9x of FY26 IND AS EBITDA. The target business reported a revenue of ₹26.95 crores for FY 2025-26 and provides Vijaya with an established operating base to enter the North-East India diagnostics market.
How strong was Vijaya Diagnostic Centre’s trading volume?
61,745 shares traded, 0.51 times the 20-day average daily volume. The price and volume data are dated 2 November 2026 · 03:30 PM IST.
Do the mutual-fund figures show buying today?
They show holdings on 30 September 2026. Quarterly holdings do not identify purchases made on the article date.
Research & analysis: WittyTrades Research Desk
Reviewed by: Mohanish Sanghavi — SEBI Registered Research Analyst
Disclaimer: Investments in securities markets are subject to market risks. Registration with SEBI and NISM certification do not guarantee performance or returns. This article is for information and education, not personalised investment advice or a recommendation to buy, sell or hold.